1 – 10 of 648
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Vägar till svensk legitimation för läkare utbildade i tredje land
(
- Contribution to journal › Article
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
(
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by ABO, F8, and VWF variants in a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease : A Systematic Review and Pharmacovigilance Update
(
- Contribution to journal › Article
-
Mark
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history : A prospective population-based study
2025) In British Journal of Haematology(
- Contribution to journal › Article
- 2024
-
Mark
Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
(
- Contribution to journal › Article
-
Mark
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
(
- Contribution to journal › Article
-
Mark
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
(
- Contribution to journal › Article
-
Mark
Recombinant FVIII replacement products for haemophilia A : An updated valuation by indirect comparison measuring area under the curve
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tissue factor (F3) gene variants and thrombotic risk among middle-aged and older adults : A population-based cohort study
(
- Contribution to journal › Article